Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hohaus, S
Right arrow Articles by Leone, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hohaus, S
Right arrow Articles by Leone, G
Haematologica, Vol 82, Issue 3, 262-268
Copyright © 1997 by Ferrata Storti Foundation

Comparative Study

Telomerase activity in human hematopoietic progenitor cells

S Hohaus, MT Voso, E Orta-La Barbera, S Cavallo, A Bellacosa, S Rutella, C Rumi, M Genuardi, G Neri, and G Leone

Department of Medical Genetics, Universita Cattolica S. Cuore, Rome, Italy. stefan_hohaus@krzmail.krz.uni-heidelberg.de

BACKGROUND AND OBJECTIVE: Telomerase is the enzyme that stabilizes and elongates the telomeric ends of chromosomes. It is expressed in germline and malignant cells and absent in most human somatic cells. The selective expression of telomerase has thus been proposed to be a basis for the immortality of germline and malignant cells. Recently, telomerase activity has been observed in human bone marrow (BM) and peripheral blood (PB) samples. The objective of our study was to further characterize the telomerase-expressing population in BM and PB. METHODS: CD34+ cells were isolated from BM and PB, cultured in vitro, and telomerase activity was assessed by the PCR-based TRAP assay. RESULTS: Telomerase activity in human BM and PB could be almost exclusively assigned to the hematopoietic progenitor cell fraction expressing the CD34 antigen. We observed telomerase activity in CD34+ cells from BM and cytokine-mobilized PB. CD34+ cells lacking co-expression of CD33 demonstrated higher levels of telomerase than myeloid committed CD34+/CD33+ cells. In vitro culture of CD34+ cells in the presence of a cocktail of growth factors inducing differentiation resulted in a decrease of telomerase activity. Telomerase activity increased in peripheral blood during cytokine-induced mobilization of hematopoietic progenitor cells. INTERPRETATION AND CONCLUSIONS: Our data demonstrate that at least a portion of the hematopoietic stem/progenitor cell fraction expresses telomerase and downregulates its expression through differentiation.


This article has been cited by other articles:


Home page
 BloodHome page
E. Samper, P. Fernandez, R. Eguia, L. Martin-Rivera, A. Bernad, M. A. Blasco, and M. Aracil
Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells
Blood, April 15, 2002; 99(8): 2767 - 2775.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
K. N. Prasad, A. R. Hovland, P. Nahreini, W. C. Cole, P. Hovland, B. Kumar, and K. C. Prasad
Differentiation Genes: Are They Primary Targets for Human Carcinogenesis?
Experimental Biology and Medicine, October 1, 2001; 226(9): 805 - 813.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Sun, K.-S. Kang, I. Morita, J. E. Trosko, and C.-C. Chang
High Susceptibility of a Human Breast Epithelial Cell Type with Stem Cell Characteristics to Telomerase Activation and Immortalization
Cancer Res., December 1, 1999; 59(24): 6118 - 6123.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 1997 by the Ferrata Storti Foundation.